Salurate Overview
Salurate has developed an award-winning, cost-effective device for testing pre-eclampsia, a condition affecting around 8% of pregnant women. Without treatment, pre-eclampsia can lead to severe health issues, including high blood pressure and even death. Salurate’s single-use, non-invasive kit offers the first reliable testing method for pre-eclampsia using just a saliva sample, eliminating the need for needles or trained medical staff.
The Challenge
Salurate’s long-term vision is to provide a free, at-home testing service for women using their saliva samples. To support this, they required an app to manage user data, communicate with a central database, and alert GPs if a patient’s condition became critical. Additionally, they faced a pressing issue with their clinical trials, which had a high drop-off rate of over 50%.
The Solution
We adopted an agile approach, making iterative improvements based on user feedback and close collaboration with Salurate’s device developers. For the app’s interface, we crafted an intuitive user journey using React Native, while the backend was developed with Laravel to ensure robustness and scalability.
The Impact
The introduction of the app led to a dramatic reduction in drop-off rates during testing, falling to under 5%. This improvement provided sufficient data to validate new clinical trials and initiate further pilot schemes with health authorities in Denmark and China.
Testimonials
“Diversification is key, and having a tech partner like Evolved—who we can rely on for expertise beyond our in-house capabilities—has been crucial in securing new business, entering new markets, and staying competitive. Their deep understanding and adaptable approach transformed a brilliant idea into a life-saving product.”
— Nigel Clarke, CEO, Salurate / Morgan Innovation and Technology